Exploring prognostic values of DNA ploidy, stroma-tumor fraction and nucleotyping in stage II colon cancer patients.

Yutong LouLujing YangShaojun XuLuxin TanYanhua BaiLin WangTingting SunLixin ZhouLi FengShenyi LianAiwen WuZhong-Wu Li

Published in: Discover oncology (2024)

Our study has proven nucleotyping and the combination of DNA ploidy and nucleotyping as independent prognostic indicators, thus expanding the application of nucleotyping as a predictor from high risk stage II colon cancer to whole risks.

Keyphrases

circulating tumor
cell free
single molecule
risk assessment
circulating tumor cells